Making medicines affordable

Cipla Chairman Dr Yusuf Hamied donates Rs 8.7 Crore to Royal Society of Chemistry for next leg of Inspirational Science Programme.

geetanjali

Geetanjali Minhas | March 7, 2019 | Mumbai


#Inspirational Science Programme   #Royal Society of Chemistry   #Yusuf Hamied   #licensing   #India   #medicine   #Cipla  
Royal Society of Chemistry in India announces funding boost from philanthropist Dr Yusuf Hamied
Royal Society of Chemistry in India announces funding boost from philanthropist Dr Yusuf Hamied

Calling for a pragmatic and compulsive licensing system in healthcare, chairperson, Cipla, Dr Yusuf Hamied said that government must formalise essential drugs. Making a strong voice for compulsory licensing and voluntary licensing to make medicine affordable, he said that when a multinational company does not give individual license for essential drugs the government should step in, ask for license and give royalty payment. “Science has to be rewarded but not denied,” he said.      

Citing the example of multinational company, Gilead Sciences Inc.– that entered into voluntary licensing agreement against royalty payment for Hepatitis-C drug 'Sofosbovir' which brought down prices for patents in India – he said that out of the world’s 50 top selling drugs, 70 percent are made and marketed by companies that did not invent them and are in-licensed. “India should in-license. With 1.35 billion people in our country who cannot afford monopoly and despite very high malnutrition in India, Vitamin B1, B2, B6 Vitamin D, Vitamin E and Vitamin C are not made in India. We have to be self-reliant and not self-sufficient,” said the renowned scientist and business leader. He was announcing his continued support and expansion of Inspirational Science Programme along with the Royal Society of Chemistry (RSC) in India with a donation of Rs 8.7 crore.
 
The four year programme will train 20,000 teachers covering most regions in India and reach out to 2,400 under privileged students under Salters’ Chemistry Camps. Since its first phase, which started in Bangalore, the Yusuf Hamied Inspirational Chemistry Programme has trained 23,000 science teachers across 9,000 schools in 26 states between 2014 and 2018. More than 1,600 students from 500 schools attended 26 Salters’ Chemistry camps.
 
The four year programme will provide Indian teachers new tools for delivering engaging and effective science lessons and encourage students to reach the necessary standards to study science at university. “A main part of the new programme will be to explore the introduction of three new key enhancements, to translate teacher training content into selected local languages, to develop training modules to cover additional specific disciplines and to explore how mobile access to the Royal Society of Chemistry’s teaching resources could complement the programmes aims. After an exploratory phase, implementation of any additional activities would commence from 2020 onwards,” said Dr. Robert Parker, chief executive of the Royal Society of Chemistry.
 
Speaking to Governance Now Dr Parker said, “Science can be a creative and fulfilling career for children and have benefits for the world. India has massive talent that could be working on inspirational chemistry as we need chemistry developments to make life better – be it in the area of health care, renewable energy or environment. With 23,000 teachers in its first phase, it was three times the original number of teachers we had set out to train. The programme is developed from feedback received by the teachers in India to make it more relevant and suitable for them and the children they are trying to engage with.” 
 
Dr Hameid added that the next programme will be practical in nature and adapt to India’s needs particularly in the area of medicines. “We are toying with the idea to see how chemistry can be taught long distance and asked RSC to expand it into science. Along with science programmes, students will be taught to develop skills and use the knowledge imparted to be more productive. Our next set up with RSC is how we get in technology we don’t have in India to make some older drugs that we are not producing,” he said.  
 

Comments

 

Other News

India’s Semiconductor Mission takes giant leap

The union cabinet on Thursday approved the establishment of three semiconductor units under ‘Development of Semiconductors and Display Manufacturing Ecosystems in India’. Involving a total investment of nearly Rs 1.26 lakh crore, the three units  -- two in Gujarat, one in Assam – wil

Mumbai Airport: Less congestion, fewer delays, says MoCA

Mumbai is one of busiest airports in India, handling a large volume of domestic and international flights including military, non-scheduled and general aviation flights. Mumbai`s Chhatrapati Shivaji Maharaj International Airport (CSMIA) has two intersecting runways which cannot be operated

“900 tenders worth Rs 150 crore?” For ward-level works: BMC

BrihanMumbai municipal corporation is floating nearly 900 tenders worth of Rs 150 crore in the next 10 days, but that is only for ward-level civic works, the BMC clarified on Monday, reacting to reports in a section of media.    “Since there are 25 wards in BMC, it involves m

Elections 2024: Banks, post offices to chip in for voter education

In a first-of-its-kind initiative, Election Commission of India (ECI) on Monday signed a memorandum of understanding (MoU) with two prominent organisations, the Indian Banks’ Association (IBA) and the Department of Posts (DoP), to amplify its voter outreach and awareness efforts ahead of the forthcom

Charming tales of the Snakeman’s early years

Snakes, Drugs and Rock ’N’ Roll: My Early Years By Romulus Whitaker with Janaki Lenin HarperCollins, 400 pages, Rs 699

Gripping graphic narrative helps make sense of pandemics past

The Moral Contagion By Julia Hauser and Sarnath Banerjee HarperCollins, 140 pages, Rs 699 The world has lar

Visionary Talk: Amitabh Gupta, Pune Police Commissioner with Kailashnath Adhikari, MD, Governance Now


Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter